Tropomyosin1抗体;Tropomyosin1 Antibody—艾普蒂 新品

+ +

•  

   

     Western blot analysis of Tropomyosin 1 expression in Human heart lysate.    

  
  

Tropomyosin 1 (TPM1) is a member of the tropomyosin family of actin-binding proteins that play critical roles in stabilizing cytoskeletal filaments and regulating cell motility, shape, and contractility. These proteins are expressed in tissue-specific isoforms due to alternative splicing, with TPM1 predominantly found in non-muscle cells, though it also contributes to muscle contraction in striated and smooth muscles. TPM1 binds to actin filaments, modulating their interaction with other proteins like myosin, thereby influencing cellular processes such as cytokinesis, intracellular transport, and mechanical stability.

Antibodies targeting TPM1 are widely used in research to study its expression, localization, and functional roles in both physiological and pathological contexts. In cancer biology, TPM1 dysregulation has been linked to tumor progression, metastasis, and altered cell adhesion, making its antibodies valuable tools for investigating cytoskeletal remodeling in malignancies. Additionally, TPM1 autoantibodies have clinical relevance in autoimmune diseases, particularly ulcerative colitis, where they serve as diagnostic biomarkers.

These antibodies are employed in techniques like Western blotting, immunofluorescence, and immunohistochemistry to analyze tissue-specific expression patterns or post-translational modifications. Their specificity is critical due to high sequence homology among tropomyosin isoforms. Research using TPM1 antibodies continues to unravel its dual roles in maintaining cytoskeletal integrity and contributing to disease mechanisms, bridging structural biology and clinical applications.